The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Corvus Pharmaceuticals, Inc. Common 221015100 13,102,464 3,275,616 SH SOLE 3,275,616 0 0
DoorDash, Inc. Class A 25809K105 1,285,303 5,214 SH OTR 5,214 0 0
Palvella Therapeutics, Inc. Common 697947109 6,739,144 298,986 SH SOLE 298,986 0 0
Paymentus Holdings, Inc. Common- Class A 70439P108 10,007,352 305,568 SH OTR 305,568 0 0
Rimini Street, Inc. Common 76674Q107 88,841,682 23,565,433 SH SOLE 23,565,433 0 0
Samsara, Inc. Common- Class A 79589L106 22,001,721 553,085 SH OTR 553,085 0 0